# Pregiolo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pregiolo

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.pregbio.com
- Latest round: Angel (Dec 30, 2022)
- Investors on record: 2

## About

Established in 2021, and based in Shenzhen, China, Renchen Biomedical Technology (Shenzhen) business named Pregiolo is a medical equipment company that provides noninvasive prenatal screening services and related products. The company was co-established by Stephen James Lye, a faculty at Mount Sinai Hospital of Toronto Canada, and Yanxing Wei, a postdoctoral fellow at the University of Toronto Canada. 

Pregiolo provides noninvasive prenatal screening technology and related products. Its products include early screening and diagnosis of preterm birth, pre-eclampsia and fetal malformations, TORCH pregnancy self-test kits, and post-prenatal rehabilitation products. The products of early screening and diagnosis of preterm birth, and pre-eclampsia, which used the technologies of artificial intelligence (AI), and stem cell isolation and enrichment, performed screening in 18 gestational weeks, and competitor's products in 20 gestational weeks. And noninvasive prenatal screening pipeline can advance the screening gestational week to 6-8 weeks. It also provides genital tract pathogen detection, TORCH detection, folic acid detection, GBS detection, and artificial placentas.

## Funding rounds

- Angel, Dec 30, 2022 — Goldport Capital
- Angel, Sep 20, 2022 — ASB Ventures

## Investors

- ASB Ventures (https://capitalatlas.ai/funds/asb-ventures) — Angel
- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Angel